Antibody therapies for the prevention and treatment of viral infections.
about
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies.Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?
P2860
Antibody therapies for the prevention and treatment of viral infections.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Antibody therapies for the prevention and treatment of viral infections.
@en
Antibody therapies for the prevention and treatment of viral infections.
@nl
type
label
Antibody therapies for the prevention and treatment of viral infections.
@en
Antibody therapies for the prevention and treatment of viral infections.
@nl
prefLabel
Antibody therapies for the prevention and treatment of viral infections.
@en
Antibody therapies for the prevention and treatment of viral infections.
@nl
P2860
P1433
P1476
Antibody therapies for the prevention and treatment of viral infections
@en
P2093
Ningyan Zhang
Zhiqiang An
P2860
P2888
P356
10.1038/S41541-017-0019-3
P577
2017-07-10T00:00:00Z